Search results

I'm impressed that they've had such a long life span!

There are two issues here. The first is whether the test is a highly accurate measure of the antibody titre in the individual. I am suggesting it isn't due to sampling and processing variability. The second is whether the level of circulating antibodies will help prevent infection during the...

The FDA advice is correct, the tests do not indicate how "protected" you are. The tests are not reliable enough for any sort of quantitative prediction about "protection". The test shows that you have seroconverted and that is all that matters as far as the test goes.

Convenience studies like this don't provide direct evidence about cause-effect relationships like this, yet that is what they are trying to suggest in the conclusion...

It's funny how patients are never included as part of the Delphi method review group. No long-covid patients want this to be called "Post COVID Syndrome". One key problem with their criteria is that it poorly discriminates between individuals who have pulmonary damage and those who have other...

:nailbiting:

That would be more than "a bit dry"

@hope123 Additionally, I partially identify with the "Maria" case study (on a disability pension, no partner or kids), although I am much younger and have been ill since I was a teenager (and I have a different pattern of symptoms). I can tell you that the proposed interventions for Maria, are...